Acute rejection · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
Leucopenia · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
D+/R‐ serostatus: symptomatic CMV · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
D+ or D‐/R+ serostatus: symptomatic CMV · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
All symptomatic CMV disease · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
All‐cause mortality · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
Graft loss · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
Taking adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in taking adherence compared with standard care (low certainty).
1 finding from 1 review
Dosing adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence may leads to higher dosing adherence compared with standard care (low certainty).
1 finding from 1 review
Timing adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in timing adherence compared with standard care (low certainty).
1 finding from 1 review
Drug holidays · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in drug holidays compared with standard care (low certainty).
1 finding from 1 review
Adherence · solid organ transplant recipients
It is very uncertain whether interventions for increasing immunosuppressant medication adherence changes self‐reported adherence (proportion) compared with standard care (very low certainty).
2 findings from 1 review
Proportion of immunosuppressant trough concentration levels at target · solid organ transplant recipients
It is very uncertain whether interventions for increasing immunosuppressant medication adherence changes proportion of immunosuppressant trough concentration levels at target compared with standard care (very low certainty).
1 finding from 1 review
All symptomatic CMV disease · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
CMV organ involvement · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
Acute rejection · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
All‐cause mortality · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
Graft loss · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
Leucopenia · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
Discontinuation of medication due to adverse events · pre‐existing and new‐onset diabetes in kidney transplant recipients
1 finding from 1 review